13F Insight
DOSSIER · 13F Holders · Q3 2025Healthcare · Biotechnology
AKRO

AKERO THERAPEUTICS INC

4 institutions still hold AKERO THERAPEUTICS INC as of Q3 2025. Tracked across SEC 13F-HR filings, with insider and 13D/G activity surfaced alongside.

CUSIP 00973Y108·Biotechnology·4 13F holders·last filed Sep 30, 2025
Market cap
—
13F value held
$4M
visible holders
Holders
4
filers reporting
Concentration
76.73%
AXA Investment Managers S.A. #1
top holder share
AI Holders Summary · Q3 2025

4 institutions reported AKRO in Q3 2025. AXA Investment Managers S.A. leads at 76.7% of the visible book.

Top holders

Sorted by position value. Source: SEC EDGAR 13F-HR filings.

#HolderValueShares% port.Quarter
01
AXA Investment Managers S.A.
CIK 0001826635
$3M71K0.01%Q3 202502
WOLVERINE TRADING, LLC
CIK 0000927337
$1M22K0.00%Q3 202503
Hemington Wealth Management
CIK 0001838234
$070.00%Q3 202504
CONCOURSE FINANCIAL GROUP SECURITIES, INC.
CIK 0000752798
$00—Q2 2025
Insiders at AKERO THERAPEUTICS INC
Heyman Tomas J. →Xu Yuan →Cheng Andrew →Graham G. Walmsley →Judy Chou →Young Jonathan →